Finance

Lists
XLO:NASDAQ
Xilio Therapeutics Inc
US$ ८.६३
+१.५३%
(+०.१३) 1D
नोभेम्बर ६, १६:००:०० GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XLO...
Open
US$ ८.२४
High
US$ ८.६९
Low
US$ ८.२४
Mkt. cap
५.६८ करोड
Avg. vol.
१३.८२ हजार
Volume
६.७८ हजार
52-wk high
US$ ११.९०
52-wk low
US$ ६.४७
EPS
-US$ १.५४
Beta
-०.११
Shares outstanding
६५.८० लाख
No. of employees
७६
Open
US$ ८.२४
High
US$ ८.६९
Low
US$ ८.२४
Mkt. cap
५.६८ करोड
Avg. vol.
१३.८२ हजार
Volume
६.७८ हजार
52-wk high
US$ ११.९०
52-wk low
US$ ६.४७
EPS
-US$ १.५४
Beta
-०.११
Shares outstanding
६५.८० लाख
No. of employees
७६
News stories
From web sources and news partners
TradingView
TradingView
·
३९ मिनेट पहिले
Nasdaq rebounds but posts fourth straight weekly decline
巴士的報
巴士的報
·
१ घण्टा पहिले
U.S. stocks close mixed as chip rebound
Investor's Business Daily
Investor's Business Daily
·
३ घण्टा पहिले
Battered Market Needs Repair, These Big Winners Look Broken
About Xilio Therapeutics Inc
CEO-
Employees७६
Founded२०१६
HeadquartersWaltham, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Analyst
Recommendation
Action
Price target
Projected
Date
Marc Frahm
TD Cowen
Buy
Maintained
-
-
11/13/2025
Next call ५ दिनमा
नोभेम्बर १२, बिहि, १६:३०
Fiscal period
Q3 2026
- / -US$ १.६८
Revenue / Est. (USD)
- / ४९.२० लाख
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.९१ करोड
१.३७ करोड
१.२६ करोड
१.८७ करोड
Cost of goods sold
१.४३ करोड
-३.७९ करोड
१.९८ करोड
१.४६ करोड
Cost of revenue
१.४३ करोड
-३.७९ करोड
१.९८ करोड
१.४६ करोड
Research and development expenses
-
५.६० करोड
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
६६.७४ लाख
७४.०० लाख
६९.२८ लाख
७६.२४ लाख
Operating expense
६६.७४ लाख
६.३४ करोड
६९.२८ लाख
७६.२४ लाख
Total operating expenses
२.१० करोड
२.५५ करोड
२.६८ करोड
२.२२ करोड
Operating income
-१९.२९ लाख
-१.१८ करोड
-१.४१ करोड
-३४.९१ लाख
Other non operating income
-१.४४ करोड
२.४७ करोड
३३.०० लाख
-२८.८२ लाख
EBT including unusual items
-१.६३ करोड
१.०४ करोड
-९५.२९ लाख
-६३.७३ लाख
EBT excluding unusual items
-१.६३ करोड
१.०४ करोड
-९५.२९ लाख
-६३.७३ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-१.६३ करोड
१.०४ करोड
-९५.२९ लाख
-६३.७३ लाख
Net profit margin
-८५.४२%
७५.७०%
-७५.३४%
-३४.०९%
Earnings per share
-
-
-
-
Interest and investment income
-
-
१२.८३ लाख
-
Interest expense
-
-२५.०० लाख
-
-
Net interest expenses
-
-२५.०० लाख
१२.८३ लाख
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-१५.८९ लाख
-१.१५ करोड
-१.३८ करोड
-३१.६० लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू